Glioblastoma Drug Resistance Pathway Recognized – Neuroscience Information
Abstract: Researchers known a key signaling pathway, PI3K-beta, chargeable for chemotherapy resistance in glioblastoma. Blockading this pathway makes tumor cells extra delicate to temozolomide, a normal chemotherapy drug. This discovery gives a
